Generative design and validation of therapeutic peptides for glioblastoma based on a potential target ATP5A
Briefings in Bioinformatics · 2026
DOI: 10.1093/bib/bbag188 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2026. Verfasst von Hao Qian und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Cognitive Machines and Computational Health (CMaCH), School of Computer Science, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Mi…. Hauptthemen laut MEDLINE: Glioblastoma, Peptides, Drug Design, Brain Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major Project, China.
Abstract (Originalsprache)
Glioblastoma (GBM) remains the most aggressive tumor, urgently requiring novel therapeutic strategies. Here, we present a dry-to-wet framework combining generative modeling and experimental validation to optimize peptides targeting ATP5A, a potential peptide-binding protein for GBM. Our framework introduces the first lead-conditioned generative model, which focuses exploration on geometrically relevant regions around lead peptides and mitigates the combinatorial complexity of de novo methods. Specifically, we propose POTFlow, a Prior and Optimal Transport-based Flow-matching model for peptide optimization. POTFlow employs secondary structure information (e.g. helix, sheet, and loop) as geometric constraints, which are further refined by optimal transport to produce shorter flow paths. With this design, our method achieves state-of-the-art performance compared with five popular approaches. When applied to GBM, our method generates peptides that selectively inhibit cell viability and significantly prolong survival in a patient-derived xenograft model. As the first lead peptide-conditioned flow matching model, POTFlow holds strong potential as a generalizable framework for therapeutic peptide design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centre for Cognitive Machines and Computational Health (CMaCH), School of Computer Science, Shanghai Jiao Tong University, No. 800 Dongchuan Road, Minhang District, Shanghai 200240, China.
- QuietD Bio Co., Ltd., No. 333 Haike Road, Pudong New District, Shanghai 201210, China.
ORCID-Profile: Hao Qian, Jingyuan Zhou, Shikui Tu
Förderung
- Science and Technology Commission of Shanghai Municipality
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major Project, China
Zitieren
APA
Qian, H., You, P., Zeng, L., Zhou, J., Huang, D., Li, K., Tu, S., & Xu, L. (2026). Generative design and validation of therapeutic peptides for glioblastoma based on a potential target ATP5A. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbag188
Vancouver
Qian H, You P, Zeng L, Zhou J, Huang D, Li K, et al. Generative design and validation of therapeutic peptides for glioblastoma based on a potential target ATP5A. Briefings in Bioinformatics. 2026. doi:10.1093/bib/bbag188
BibTeX
@article{Qian2026,
author = {Qian, Hao and You, Pu and Zeng, Lin and Zhou, Jingyuan and Huang, Dengdeng and Li, Kaicheng and Tu, Shikui and Xu, Lei},
title = {Generative design and validation of therapeutic peptides for glioblastoma based on a potential target ATP5A},
journal = {Briefings in Bioinformatics},
year = {2026},
doi = {10.1093/bib/bbag188}
}
EUVIMED